DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20210673

An infant with hypertriglyceridemia presenting as failure to thrive: a case report

Rajesh K. Srinivas, Ashok Gupta, Priyanshu Mathur, Kamlesh Agarwal, Anil Sharma

Abstract


Familial hypertriglyceridemia is rare in infancy. Diagnosis in infancy is very difficult and is usually diagnosed when acute pancreatitis sets in. Early diagnosis is important as it can prevent the complications associated with acute pancreatitis and pancreatic necrosis. Here is a case familial hypertriglyceridemia in an infant who presented to us with failure to thrive but was diagnosed early due to presence of highly viscous and milky blood. This holds importance as early treatment can reduce the complications and morbidity associated with familial hypertriglyceridemia.


Keywords


Familial hypertriglyceridemia, Milky serum, Failure to thrive

Full Text:

PDF

References


Patni N, Li X, Adams-Huet B, Garg A. The prevalence and etiology of extreme hypertriglyceridemia in children: Data from a tertiary children's hospital. J Clin Lipidol. 2018;12(2):305-10.

Hegele RA, Ginsberg HN, Chapman MJ, Nordestgaard BG, Kuivenhoven JA, Averna M, et al. The polygenic nature of hypertriglyceridemia: implications for definition, diagnosis, and management. Lancet Diabet Endocrinol. 2014;2:655-66.

Fredrickson DS. An international classification of hyperlipidemias and hyperlipoproteinemias. Ann Intern Med. 1971;75:471.

Fortson MR, Freedman SN, Webster PD. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol. 1995;90:2134.

Hulley SB, Rosenman RH, Bawol RD, Brand RJ. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med. 1980;302:1383-9.

Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3(2):213-9.

Laufs U, Parhofer KG, Ginsberg HN, Hegele RA. Clinical review on triglycerides. Eur Heart J. 2020;41(1):99-109.

Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ. 2007;176(8):1113-20.

Valdivielso P, Ramirez-Bueno A, Ewald N. Current knowledge of hypertriglyceridemic pancreatitis. Eur J Intern Med. 2014;25:689.

Eckel RH, Jakicic JM, Ard JD. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines. Circulation. 2014;129:S76.

Williams LA, Wilson DP. Nutritional management of pediatric dyslipidemia. 2020 Jan 14. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, et al, editors. Endotext. South Dartmouth (MA): MDText.com, Inc. 2000–20.

Valaiyapathi B, Sunil B, Ashraf AP. Approach to Hypertriglyceridemia in the Pediatric Population. Pediatr Rev. 2017;38(9):424-34.

Nestel PJ, Connor WE, Reardon MF. Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest. 1984;74:82.

Harris WS, Connor WE, Illingworth DR. Effects of fish oil on VLDL triglyceride kinetics in humans. J Lipid Res. 1990;31:1549.